Skip to Main Content

Baxter International Inc.

BAX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
BAX Income Statement
BAX Balance Sheet
BAX Cash Flow

Recent trades of BAX by members of U.S. Congress

Politician Type Traded
Earl Blumenauer House / D Purchase $15,001 - $50,000 Jul. 09, 2024
Robert J. Wittman House / R Sale $1,001 - $15,000 Jan. 20, 2023
William R. Keating House / D Sale $1,001 - $15,000 Dec. 05, 2022
Dan Sullivan Senate / R Sale (Full) $1,001 - $15,000 Nov. 30, 2022
Robert J. Wittman House / R Purchase $1,001 - $15,000 Jul. 15, 2022
Robert J. Wittman House / R Sale $1,001 - $15,000 Jun. 16, 2022
William R. Keating House / D Purchase $1,001 - $15,000 Apr. 14, 2021
William R. Keating House / D Purchase $1,001 - $15,000 Mar. 17, 2021
Peter Meijer House / R Sale $1,001 - $15,000 Feb. 16, 2021
Dean Phillips House / D Sale $1,001 - $15,000 Dec. 18, 2020
Dean Phillips House / D Purchase $1,001 - $15,000 Sep. 23, 2020
Lois Frankel House / D Sale $1,001 - $15,000 May. 27, 2020
David Perdue Senate / R Sale (Full) $15,001 - $50,000 Apr. 14, 2020
Dean Phillips House / D Purchase $1,001 - $15,000 Apr. 02, 2020
Dean Phillips House / D Purchase $1,001 - $15,000 Feb. 28, 2020
Lois Frankel House / D Sale $1,001 - $15,000 Jan. 29, 2020
Dean Phillips House / D Sale $1,001 - $15,000 Nov. 22, 2019
Dean Phillips House / D Sale $1,001 - $15,000 Sep. 11, 2019
Dean Phillips House / D Purchase $1,001 - $15,000 Aug. 13, 2019
Lois Frankel House / D Sale $1,001 - $15,000 Feb. 28, 2019
Susie Lee House / D Sale $1,001 - $15,000 Feb. 27, 2019
Lois Frankel House / D Sale $1,001 - $15,000 Jul. 18, 2018
Gary J. Palmer House / R Sale $1,001 - $15,000 Nov. 27, 2017
David Perdue Senate / R Sale (Partial) $15,001 - $50,000 Sep. 22, 2017
David Perdue Senate / R Sale (Partial) $15,001 - $50,000 Sep. 22, 2017
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Sep. 08, 2017
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Apr. 26, 2017
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Mar. 02, 2017
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Feb. 13, 2017
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Feb. 08, 2017
Richard L. Hanna House / R Sale $15,001 - $50,000 Dec. 28, 2016
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Nov. 08, 2016
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Nov. 07, 2016
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Oct. 12, 2016
Mo Brooks House / R Sale $1,001 - $15,000 Aug. 31, 2016
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Aug. 30, 2016
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Aug. 26, 2016
David Perdue Senate / R Sale (Partial) $1,001 - $15,000 Aug. 25, 2016
Lois Frankel House / D Purchase $1,001 - $15,000 Jan. 15, 2016
Lois Frankel House / D Purchase $1,001 - $15,000 Jan. 15, 2016
Lois Frankel House / D Purchase $1,001 - $15,000 Nov. 23, 2015
Raúl M. Grijalva House / D Sale $1,001 - $15,000 Oct. 15, 2015
David Perdue Senate / R Purchase $1,001 - $15,000 Aug. 28, 2015
David Perdue Senate / R Purchase $1,001 - $15,000 Aug. 27, 2015
David Perdue Senate / R Purchase $1,001 - $15,000 Aug. 27, 2015
David Perdue Senate / R Purchase $1,001 - $15,000 Aug. 26, 2015
David Perdue Senate / R Purchase $1,001 - $15,000 Aug. 25, 2015
David Perdue Senate / R Purchase $1,001 - $15,000 Aug. 24, 2015
David Perdue Senate / R Purchase $1,001 - $15,000 Aug. 21, 2015
David Perdue Senate / R Purchase $1,001 - $15,000 Aug. 21, 2015
BAX Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
BAX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
BAX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by BAX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $30,000 Jan 06, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Oct 13, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jul 12, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Apr 08, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jan 07, 2021 Issue: Medicare/Medicaid Health Issues

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Water purification apparatus and methods for cleaning the water purification apparatus Nov. 05, 2024
  • Patent Title: Durable, multi-use peritoneal dialysis cycler using disinfection Nov. 05, 2024
  • Patent Title: Peritoneal dialysis cycler having dual peristaltic pumps Nov. 05, 2024
  • Patent Title: Medical device data integration apparatus and methods Oct. 29, 2024
  • Patent Title: Daptomycin formulations containing a combination of sorbitol and mannitol Oct. 29, 2024
  • Patent Title: Syringe pump with syringe position guiding features and occlusion detection Oct. 22, 2024
  • Patent Title: Reconstitution device, system, and method to administer a drug in a moderate bolus Oct. 22, 2024
  • Patent Title: Chest-based physiological monitor Oct. 22, 2024
  • Patent Title: Peritoneal dialysis system including manifold assembly and peristaltic pump Sep. 24, 2024
  • Patent Title: Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation Sep. 24, 2024
  • Patent Title: System and method for self-aligning hub connector Sep. 17, 2024
  • Patent Title: Surgical adhesive able to glue in wet conditions Sep. 17, 2024
  • Patent Title: Monitor outlet Sep. 17, 2024
  • Patent Title: Parenteral nutrition diagnostic system, apparatus, and method Sep. 10, 2024
  • Patent Title: Priming sensor for a medical fluid delivery system Aug. 13, 2024
  • Patent Title: Medical fluid container preparation system and assembly Jul. 23, 2024
  • Patent Title: System and method for generating battery alarms in infusion devices Jul. 23, 2024
  • Patent Title: Dialysis systems and methods including sensor feedback to improve patient experience Jul. 23, 2024
  • Patent Title: Anti-occlusion intravenous tube port Jul. 16, 2024
  • Patent Title: Systems for performing peritoneal dialysis Jul. 16, 2024
  • Patent Title: Dialysis patient connector and method for priming Jul. 09, 2024
  • Patent Title: Blood treatment air purging system and method Jul. 02, 2024
  • Patent Title: System and method to efficiently clean a blood filter Jul. 02, 2024
  • Patent Title: Medical fluid delivery system including a mobile platform for patient engagement and treatment compliance Jun. 25, 2024
  • Patent Title: Peritoneal dialysis system having disinfection fluid pumping and pathway Jun. 18, 2024
  • Patent Title: Medical fluid delivery system including remote machine updating and control Jun. 18, 2024
  • Patent Title: Systems and methods for head height pressure compensation May. 28, 2024
  • Patent Title: Hemodialysis system including a disposable set and a dialysis instrument May. 07, 2024
  • Patent Title: Medical product including pre-filled product bag May. 07, 2024
  • Patent Title: Medical device audible and visual alarm synchronization Apr. 23, 2024
  • Patent Title: Graph database for outbreak tracking and management Apr. 23, 2024
  • Patent Title: Digital communication module for transmission of data from a medical device Apr. 16, 2024
  • Patent Title: System and method for electronic identification of remote peritoneal dialysis exchanges Apr. 16, 2024
  • Patent Title: Volume-based flow rate compensation technique for infusion therapy Apr. 09, 2024
  • Patent Title: Method for trending automated peritoneal dialysis treatments Apr. 09, 2024
  • Patent Title: Handheld physiological sensor Apr. 09, 2024
  • Patent Title: System and method for monitoring and determining patient parameters from sensed venous waveform Apr. 09, 2024
  • Patent Title: Medical fluid therapy machine including pneumatic pump box and accumulators therefore Apr. 02, 2024
  • Patent Title: Containers with selective dissolved gas content Apr. 02, 2024
  • Patent Title: Optimizing efficiency of a water purification apparatus Mar. 26, 2024
  • Patent Title: System and method for preparing peritoneal dialysis fluid at the time of use Mar. 19, 2024
  • Patent Title: Port arrangement, a purified water producing apparatus comprising the port arrangement and a method for performing port cleaning of a purified water producing apparatus Mar. 19, 2024
  • Patent Title: Balanced flow dialysis machine Mar. 19, 2024
  • Patent Title: Device and method for sensing signals from a body Mar. 19, 2024
  • Patent Title: Method and composition for removing uremic toxins Mar. 12, 2024
  • Patent Title: Devices for urea electrolysis and methods of using same Mar. 12, 2024
  • Patent Title: Dialysis system having adaptive prescription management Mar. 05, 2024
  • Patent Title: Peritoneal dialysis system including manifold assembly and peristaltic pump Feb. 27, 2024
  • Patent Title: System for removing uremic toxins in dialysis processes Feb. 27, 2024
  • Patent Title: Device, system and method for mixing Feb. 13, 2024
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of BAX in WallStreetBets Daily Discussion

BAX News

Recent insights relating to BAX

CNBC Recommendations

Recent picks made for BAX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BAX

BAX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view BAX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top